Mangalam Drugs & Organics Limited (NSE:MANGALAM)
India · Delayed Price · Currency is INR 89.22
-1.45 (-1.60%)
Jul 25, 2025, 3:29 PM IST
Mangalam Drugs & Organics Market Cap
Mangalam Drugs & Organics has a market cap or net worth of 1.41 billion as of July 25, 2025. Its market cap has decreased by -20.81% in one year.
Market Cap
1.41B
Enterprise Value
2.35B
Revenue
3.18B
Ranking
n/a
PE Ratio
21.00
Stock Price
89.22
Market Cap Chart
Since May 24, 2005, Mangalam Drugs & Organics's market cap has increased from 214.36M to 1.41B, an increase of 558.42%. That is a compound annual growth rate of 9.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 1.41B | -22.73% |
| Dec 31, 2024 | 1.83B | 17.53% |
| Dec 29, 2023 | 1.55B | -28.41% |
| Dec 30, 2022 | 2.17B | 5.87% |
| Dec 31, 2021 | 2.05B | -7.50% |
| Dec 31, 2020 | 2.22B | 401.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,059.67B |
| Divi's Laboratories | 1,757.00B |
| Cipla | 1,201.85B |
| Mankind Pharma | 1,072.68B |
| Apollo Hospitals Enterprise | 1,060.20B |
| Zydus Lifesciences | 977.30B |
| Aurobindo Pharma | 647.07B |
| Fortis Healthcare | 639.11B |